Circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) longitudinal monitoring of metastatic breast cancer (MBC).

被引：0
|
作者：
Costa, Ricardo Lima Barros
Rossi, Giovanna
Mu, Zhaomei
Austin, Laura Katherine
Rademaker, Alfred
Gradishar, William John
Santa-Maria, Cesar Augusto
Jain, Sarika
Flaum, Lisa E.
Giles, Francis J.
Yang, Hushan
Cristofanilli, Massimo
机构：
[1] Northwestern Univ, Northwestern Med Dev Therapeut Inst, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA
[2] Ist Oncol Veneto IRCCS IOV, Padua, Italy
[3] Kimmel Canc Ctr Jefferson, Philadelphia, PA USA
[4] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA
[5] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[6] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA
[7] Northwestern Univ, Div Hematol Oncol, Chicago, IL 60611 USA
[8] Hem Onc Assocs, Chicago, IL USA
[9] HRB Clin Res Facil Galaway, Chicago, IL USA
[10] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA
[11] Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e23030
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e23030
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Circulating tumor DNA (ctDNA) as a molecular monitoring tool in metastatic breast cancer (MBC)
    Austin, Laura Katherine
    Fortina, Paolo
    Sebisanovic, Dragan
    Siew, LaiMun
    Zapanta, Aubrey
    Talasaz, AmirAli
    Cristofanilli, Massimo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [2] Can the enumeration of circulating tumor cells (CTCs) and the characterization of circulating tumor DNA (ctDNA) provide insight into organ tropism in metastatic breast cancer (MBC)?
    Gerratana, Lorenzo
    Zhang, Qiang
    Shah, Ami N.
    Davis, Andrew A.
    Zhang, Youbin
    Wehbe, Firas
    Qiang, Wenan
    Flaum, Lisa E.
    Finkelman, Brian
    Gradishar, William John
    Platanias, Leonidas C.
    Behdad, Amir
    Cristofanilli, Massimo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] Longitudinal Dynamics of Circulating Tumor Cells and Circulating Tumor DNA for Treatment Monitoring in Metastatic Breast Cancer
    Gerratana, Lorenzo
    Davis, Andrew A.
    Zhang, Qiang
    Basile, Debora
    Rossi, Giovanna
    Strickland, Kimberly
    Franzoni, Alessandra
    Allegri, Lorenzo
    Mu, Zhaomei
    Zhang, Youbin
    Flaum, Lisa E.
    Damante, Giuseppe
    Gradishar, William John
    Platanias, Leonidas C.
    Behdad, Amir
    Yang, Hushan
    Puglisi, Fabio
    Cristofanilli, Massimo
    [J]. JCO PRECISION ONCOLOGY, 2021, 5 : 943 - 952
  • [4] Landscape of circulating tumor DNA (ctDNA) in metastatic breast cancer
    Davis, Andrew A.
    Jacob, Saya
    Gerratana, Lorenzo
    Shah, Ami N.
    Wehbe, Firas
    Katam, Neelima
    Zhang, Qiang
    Flaum, Lisa
    Siziopikou, Kalliopi
    Platanias, Leonidas C.
    Gradishar, William J.
    Behdad, Amir
    Cristofanilli, Massimo
    [J]. CANCER RESEARCH, 2020, 80 (04)
  • [5] Longitudinal circulating tumor DNA (ctDNA) monitoring by digital droplet PCR (ddPCR) in metastatic breast cancer
    Higashiyama, Nicole
    Williams, LaTerrica
    McCue, Bryant
    Kuriakose, Alphi
    Tran, Tiffaney
    Gonzalez, Stephanie
    Licerio, Mayra
    Chenault, Carol
    Dowst, Heidi
    Hilsenbeck, Susan
    Ellis, Matthew
    Lim, Bora
    Miles, George
    [J]. CANCER RESEARCH, 2022, 82 (04)
  • [6] ESR1 mutations in circulating tumor DNA (ctDNA) are associated with CTCs and increased hormone receptors in metastatic tumor tissues of patients with metastatic breast cancer (MBC).
    Zhang, Qiang
    Qin, Weijun
    D'Amico, Paolo
    Jiao, Jianhua
    Davis, Andrew A.
    Gerratana, Lorenzo
    Donahue, Jeannine
    Reduzzi, Carolina
    Manai, Marwa
    Jacob, Saya
    Zhang, Youbin
    Flaum, Lisa E.
    Behdad, Amir
    Cristofanilli, Massimo
    Platanias, Leonidas C.
    Shah, Ami N.
    Gradishar, William John
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [7] Genomic profiling of circulating tumor DNA (ctDNA) from patients (pts) with metastatic breast cancer (mBC).
    Pusztai, Lajos
    Chung, Jon
    Young, Lauren
    Schrock, Alexa Betzig
    Hartmaier, Ryan
    Frampton, Garrett Michael
    Gay, Laurie M.
    Stephens, Phil
    Miller, Vincent A.
    Ali, Siraj Mahamed
    Ross, Jeffrey S.
    Vahdat, Linda T.
    O'Shaughnessy, Joyce
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [8] Circulating tumor cells (CTCs) and molecular subtypes (MST) in a treatment algorithm for metastatic breast cancer (MBC)
    Graham, Mark
    Fleming, Natanya
    Blumenthal, Susan
    Boehlke, Brittani
    Schuur, Eric
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [9] Circulating tumor cells (CTCs) and association with survival in molecular subtypes (MST) of metastatic breast cancer (MBC)
    Graham, M.
    Fleming, N.
    Pinto, A.
    Dropkin, E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [10] Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization
    Gradilone, A.
    Naso, G.
    Raimondi, C.
    Cortesi, E.
    Gandini, O.
    Vincenzi, B.
    Saltarelli, R.
    Chiapparino, E.
    Spremberg, F.
    Cristofanilli, M.
    Frati, L.
    Agliano, A. M.
    Gazzaniga, P.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 (01) : 86 - 92
12345